969 related articles for article (PubMed ID: 1710777)
1. Pain in sickle cell disease. Rates and risk factors.
Platt OS; Thorington BD; Brambilla DJ; Milner PF; Rosse WF; Vichinsky E; Kinney TR
N Engl J Med; 1991 Jul; 325(1):11-6. PubMed ID: 1710777
[TBL] [Abstract][Full Text] [Related]
2. Mortality in sickle cell disease. Life expectancy and risk factors for early death.
Platt OS; Brambilla DJ; Rosse WF; Milner PF; Castro O; Steinberg MH; Klug PP
N Engl J Med; 1994 Jun; 330(23):1639-44. PubMed ID: 7993409
[TBL] [Abstract][Full Text] [Related]
3. Sickle cell disease as a cause of osteonecrosis of the femoral head.
Milner PF; Kraus AP; Sebes JI; Sleeper LA; Dukes KA; Embury SH; Bellevue R; Koshy M; Moohr JW; Smith J
N Engl J Med; 1991 Nov; 325(21):1476-81. PubMed ID: 1944426
[TBL] [Abstract][Full Text] [Related]
4. Prediction of adverse outcomes in children with sickle cell disease.
Miller ST; Sleeper LA; Pegelow CH; Enos LE; Wang WC; Weiner SJ; Wethers DL; Smith J; Kinney TR
N Engl J Med; 2000 Jan; 342(2):83-9. PubMed ID: 10631276
[TBL] [Abstract][Full Text] [Related]
5. Acute splenic sequestration in female children with sickle cell disease in the North of Jordan.
Al-Rimawi HS; Abdul-Qader M; Jallad MF; Amarin ZO
J Trop Pediatr; 2006 Dec; 52(6):416-20. PubMed ID: 16951418
[TBL] [Abstract][Full Text] [Related]
6. High-dose intravenous methylprednisolone therapy for pain in children and adolescents with sickle cell disease.
Griffin TC; McIntire D; Buchanan GR
N Engl J Med; 1994 Mar; 330(11):733-7. PubMed ID: 8107739
[TBL] [Abstract][Full Text] [Related]
7. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.
Embury SH; Dozy AM; Miller J; Davis JR; Kleman KM; Preisler H; Vichinsky E; Lande WN; Lubin BH; Kan YW; Mentzer WC
N Engl J Med; 1982 Feb; 306(5):270-4. PubMed ID: 6172710
[TBL] [Abstract][Full Text] [Related]
8. A randomized study of outpatient treatment with ceftriaxone for selected febrile children with sickle cell disease.
Wilimas JA; Flynn PM; Harris S; Day SW; Smith R; Chesney PJ; Rodman JH; Eguiguren JM; Fairclough DL; Wang WC
N Engl J Med; 1993 Aug; 329(7):472-6. PubMed ID: 8332152
[TBL] [Abstract][Full Text] [Related]
9. Lack of influence of fetal hemoglobin levels or erythrocyte indices on the severity of sickle cell anemia.
Powars DR; Schroeder WA; Weiss JN; Chan LS; Azen SP
J Clin Invest; 1980 Mar; 65(3):732-40. PubMed ID: 6153392
[TBL] [Abstract][Full Text] [Related]
10. Augmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.
Rodgers GP; Dover GJ; Uyesaka N; Noguchi CT; Schechter AN; Nienhuis AW
N Engl J Med; 1993 Jan; 328(2):73-80. PubMed ID: 7677965
[TBL] [Abstract][Full Text] [Related]
11. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
Italia K; Jain D; Gattani S; Jijina F; Nadkarni A; Sawant P; Nair S; Mohanty D; Ghosh K; Colah R
Blood Cells Mol Dis; 2009; 42(1):25-31. PubMed ID: 18954999
[TBL] [Abstract][Full Text] [Related]
12. Genetic Blood Disorders Survey in the Sultanate of Oman.
Al-Riyami A; Ebrahim GJ
J Trop Pediatr; 2003 Jul; 49 Suppl 1():i1-20. PubMed ID: 12934793
[TBL] [Abstract][Full Text] [Related]
13. Newborn screening for sickle cell disease: effect on mortality.
Vichinsky E; Hurst D; Earles A; Kleman K; Lubin B
Pediatrics; 1988 Jun; 81(6):749-55. PubMed ID: 3368274
[TBL] [Abstract][Full Text] [Related]
14. Incidence and natural history of proliferative sickle cell retinopathy: observations from a cohort study.
Downes SM; Hambleton IR; Chuang EL; Lois N; Serjeant GR; Bird AC
Ophthalmology; 2005 Nov; 112(11):1869-75. PubMed ID: 16171867
[TBL] [Abstract][Full Text] [Related]
15. Assessing clinical severity in children with sickle cell disease. Preliminary results from a cooperative study.
Bray GL; Muenz L; Makris N; Lessin LS
Am J Pediatr Hematol Oncol; 1994 Feb; 16(1):50-4. PubMed ID: 8311173
[TBL] [Abstract][Full Text] [Related]
16. A comparison of conservative and aggressive transfusion regimens in the perioperative management of sickle cell disease. The Preoperative Transfusion in Sickle Cell Disease Study Group.
Vichinsky EP; Haberkern CM; Neumayr L; Earles AN; Black D; Koshy M; Pegelow C; Abboud M; Ohene-Frempong K; Iyer RV
N Engl J Med; 1995 Jul; 333(4):206-13. PubMed ID: 7791837
[TBL] [Abstract][Full Text] [Related]
17. The interaction of alpha-thalassemia and homozygous sickle-cell disease.
Higgs DR; Aldridge BE; Lamb J; Clegg JB; Weatherall DJ; Hayes RJ; Grandison Y; Lowrie Y; Mason KP; Serjeant BE; Serjeant GR
N Engl J Med; 1982 Jun; 306(24):1441-6. PubMed ID: 6176865
[TBL] [Abstract][Full Text] [Related]
18. Mortality in children and adolescents with sickle cell disease. Cooperative Study of Sickle Cell Disease.
Leikin SL; Gallagher D; Kinney TR; Sloane D; Klug P; Rida W
Pediatrics; 1989 Sep; 84(3):500-8. PubMed ID: 2671914
[TBL] [Abstract][Full Text] [Related]
19. Extended therapy with intravenous arginine butyrate in patients with beta-hemoglobinopathies.
Sher GD; Ginder GD; Little J; Yang S; Dover GJ; Olivieri NF
N Engl J Med; 1995 Jun; 332(24):1606-10. PubMed ID: 7753139
[TBL] [Abstract][Full Text] [Related]
20. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
Perrine SP; Ginder GD; Faller DV; Dover GH; Ikuta T; Witkowska HE; Cai SP; Vichinsky EP; Olivieri NF
N Engl J Med; 1993 Jan; 328(2):81-6. PubMed ID: 7677966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
